[HTML][HTML] Mass spectrometric assays monitoring the deubiquitinase activity of the SARS-CoV-2 papain-like protease inform on the basis of substrate selectivity and …

L Brewitz, HTH Chan, P Lukacik… - Bioorganic & Medicinal …, 2023 - Elsevier
Abstract The SARS-CoV-2 papain-like protease (PL pro) and main protease (M pro) are
nucleophilic cysteine enzymes that catalyze the hydrolysis of the viral polyproteins …

Drug repurposing for the SARS‐CoV‐2 papain‐like protease

CC Cho, SG Li, TJ Lalonde, KS Yang, G Yu… - …, 2022 - Wiley Online Library
As the pathogen of COVID‐19, SARS‐CoV‐2 encodes two essential cysteine proteases that
process the pathogen's two large polypeptide products pp1a and pp1ab in the human cell …

Characterization of the Ubiquitin and ISG15 Deconjugase Activity of SARS-CoV-1 and SARS-CoV-2 Papain-Like Protease

D Nayak, P dos Santos Bury, M Drag… - … : Methods and Protocols, 2022 - Springer
Both severe acute respiratory syndrome coronavirus 1 and 2 (SARS-CoV-1 and SARS-CoV-
2) encode a papain-like protease (PLpro), which plays a vital role in viral propagation. PLpro …

Characterization and noncovalent inhibition of the deubiquitinase and deISGylase activity of SARS-CoV-2 papain-like protease

BT Freitas, IA Durie, J Murray, JE Longo… - ACS infectious …, 2020 - ACS Publications
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the causative agent for
COVID-19, is a novel human betacoronavirus that is rapidly spreading worldwide. The …

Identifying SARS-CoV-2 antiviral compounds by screening for small molecule inhibitors of Nsp3 papain-like protease

CT Lim, KW Tan, M Wu, R Ulferts… - Biochemical …, 2021 - portlandpress.com
The COVID-19 pandemic has emerged as the biggest life-threatening disease of this
century. Whilst vaccination should provide a long-term solution, this is pitted against the …

Characterization and noncovalent inhibition of the K63-deubiquitinase activity of SARS-CoV-2 PLpro

X Liu, M Zheng, H Zhang, B Feng, J Li, Y Zhang… - Antiviral Research, 2024 - Elsevier
ABSTRACT SARS-CoV-2 papain-like protease (PLpro) could facilitate viral replication and
host immune evasion by respectively hydrolyzing viral polyprotein and host ubiquitin …

Inhibitors of deubiquitinating enzymes interfere with the SARS-CoV-2 papain-like protease and block virus replication in vitro

M Große, C Setz, P Rauch, J Auth, M Morokutti-Kurz… - Viruses, 2022 - mdpi.com
The ubiquitin proteasome system (UPS), particularly its deubiquitinating enzymes (DUBs),
play a key role in the replication cycle of coronaviruses. The SARS-CoV-2 papain-like …

Characterization of ubiquitin and ubiquitin‐like‐protein isopeptidase activities

B Nicholson, CA Leach, SJ Goldenberg… - Protein …, 2008 - Wiley Online Library
Conjugation or deconjugation of ubiquitin (Ub) or ubiquitin‐like proteins (UBLs) to or from
cellular proteins is a multifaceted and universal means of regulating cellular physiology …

Potent and selective covalent inhibition of the papain-like protease from SARS-CoV-2

BC Sanders, S Pokhrel, AD Labbe, II Mathews… - Nature …, 2023 - nature.com
Direct-acting antivirals are needed to combat coronavirus disease 2019 (COVID-19), which
is caused by severe acute respiratory syndrome-coronavirus-2 (SARS-CoV-2). The papain …

Identification of Small Molecule Inhibitors of the Deubiquitinating Activity of the SARS-CoV-2 Papain-Like Protease: in silico Molecular Docking Studies and in vitro …

E Pitsillou, J Liang, K Ververis, KW Lim, A Hung… - Frontiers in …, 2020 - frontiersin.org
COVID-19 is an ongoing pandemic caused by the SARS-CoV-2 virus with important political,
socio-economic, and public health consequences. Inhibiting replication represents an …